final results of avelumab and axitinib in rcc in the javelin renal 101 trial
Published 1 month ago • 26 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
0:44
real-world efficacy of avelumab and axitinib in advanced renal cell carcinoma
-
9:23
javelin renal 101: avelumab plus axitinib improve pfs for advanced renal cell cancer
-
2:03
dr. agarwal on updated results of the javelin renal 101 trial in advanced rcc
-
2:31
javelin renal 101: combination approach for advanced rcc patients | laurence albiges
-
2:27
combining avelumab and axitinib in advanced renal cell carcinoma (rcc)
-
5:10
real-world treatment outcomes of 1l axitinib pembrolizumab in patients with advanced rcc in the us
-
2:26
intrigue: ripretinib vs. sunitinib in patients with advanced gists
-
5:50
beating merkel cell carcinoma with immunotherapy
-
4:39
avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
-
0:57
avelumab and axitinib for the treatment of advanced rcc
-
3:22
biomarker analysis from javelin renal 101: avelumab plus axitinib versus sunitinib in arcc
-
3:41
tide-a: avelumab and intermittent axitinib in metastatic renal cell carcinoma
-
2:30
dr. choueiri on the subgroup analysis of the javelin renal 101 trial in rcc
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
9:30
study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
-
1:37
dr. shuch on caveats of avelumab/axitinib combination in rcc
-
1:09
dr. apolo on updated javelin results of avelumab in urothelial carcinoma
-
1:47
dr. choueiri on the impact of the javelin renal 101 findings in rcc
-
2:32
avelumab plus axitinib improves survival in advanced renal-cell carcinoma patients
-
1:49
expert comment on the javelin renal 101 trial | markus joerger
-
1:00
pembrolizumab/axitinib and avelumab/axitinib combo for rcc
-
13:05
javelin renal 101 updated results